 |
Journal articles
Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease
Abstract : PURPOSE: Alzheimer's disease (AD) may disturb functions of the blood-brain barrier and change the disposition of drugs to the brain. This study assessed the disease-induced changes in drug transporters in the brain capillaries of transgenic AD mice.
METHODS: Eighteen drug transporters and four tight junction-associated proteins were analyzed by RT-qPCR in cortex, hippocampus and cerebellum tissue samples of 12-16-month-old APdE9, Tg2576 and APP/PS1 transgenic mice and their healthy age-matched controls. In addition, microvessel fractions enriched from 1-3-month-old APdE9 mice were analyzed using RT-qPCR and Western blotting. Brain transport of methotrexate in APdE9 mice was assessed by in vivo microdialysis.
RESULTS: The expression profiles of studied genes were similar in brain tissues of AD and control mice. Instead, in the microvessel fraction in APdE9 mice, >2-fold alterations were detected in the expressions of 11 genes but none at the protein level. In control mice strains, >5-fold changes between different brain regions were identified for Slc15a2, Slc22a3 and occludin. Methotrexate distribution into hippocampus of APdE9 mice was faster than in controls.
CONCLUSIONS: The expression profile of mice carrying presenilin and amyloid precursor protein mutations is comparable to controls, but clear regional differences exist in the expression of drug transporters in brain.
https://hal-univ-artois.archives-ouvertes.fr/hal-02506588
Contributor : Virginie Justin-Labonne <>
Submitted on : Friday, July 23, 2021 - 3:42:53 PM
Last modification on : Friday, July 23, 2021 - 3:59:37 PM
Contributor : Virginie Justin-Labonne <>
Submitted on : Friday, July 23, 2021 - 3:42:53 PM
Last modification on : Friday, July 23, 2021 - 3:59:37 PM
File
Kati-sisko et al., 2017.pdf
Explicit agreement for this submission
Licence
Distributed under a Creative Commons Attribution 4.0 International License